The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis (editorial on: Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial)
Restricted accessEditorialFirst published online May, 2023
The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis (editorial on: Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial)
KuhleJChitnisTBanwellB, et al. Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial. Mult Scler2023; 29: 385–394.
2.
BittnerSOhJHavrdováEK, et al. The potential of serum neurofilament as biomarker for multiple sclerosis. Brain2021; 144: 2954–2963.
3.
MomtazmaneshSShobeiriPSaghazadehA, et al. Neuronal and glial CSF biomarkers in multiple sclerosis: A systematic review and meta-analysis. Rev Neurosci2021; 32: 573–595.
4.
VarhaugKNTorkildsenØMyhrKM, et al. Neurofilament light chain as a biomarker in multiple sclerosis. Front Neurol2019; 10: 338.
5.
BenkertPMeierSSchaedelinS, et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: A retrospective modelling and validation study. Lancet Neurol2022; 21: 246–257.
6.
WongYYMBruijstensALBarroC, et al. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes. Neurology2019; 93: e968–e974.
7.
WendelEMBertoliniAKousoulosL, et al. Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome. Mult Scler2022; 28: 1553–1561.
8.
ReinertMCBenkertPWuerfelJ, et al. Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis. Neurol Neuroimmunol Neuroinflamm2020; 7: e749.
9.
GhezziABaronciniDZaffaroniM, et al. Pediatric versus adult MS: Similar or different?Mult Scler Demyelinating Disord2017; 2: 5.
10.
De MeoEFilippiMTrojanoM, et al. Comparing natural history of early and late onset pediatric multiple sclerosis. Ann Neurol2022; 91: 483–495.
